A Phase 2 Study of LY2495655 in Participants With Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01505530
Recruitment Status : Completed
First Posted : January 6, 2012
Last Update Posted : March 11, 2016
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2014
  Actual Study Completion Date : January 2016
  Certification/Extension First Submitted : January 16, 2015